Silver Book Fact

Drug-resistant MRSA expensive to treat

As an example, the median treatment cost for drug-resistant MRSA patients over a 6-month period was 118% higher than the cost of treating drug-susceptible MRSA strains.

Mauldin P, Salgado C, Hansen I, Durup D, et al. Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic Resistant Gram-Negative Bacteria. Antimicrob Agents Chemother. 2009; 54(1): 109-15. http://aac.asm.org/content/54/1/109.full

Reference

Title
Attributable Hospital Cost and Length of Stay Associated with Health Care-Associated Infections Caused by Antibiotic Resistant Gram-Negative Bacteria
Publication
Antimicrob Agents Chemother
Publication Date
2009
Authors
Mauldin P, Salgado C, Hansen I, Durup D, et al.
Volume & Issue
Volume 54, Issue 1
Pages
109-15
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • ~3/4 of all HAIs occur outside of ICU
    Nearly 3/4 of all hospital-acquired HAIs occur outside of the intensive care unit (ICU).  
  • Mortality rate from hospital-acquired pneumonia
    The mortality rate for hospital-acquired pneumonia ranges from 38% to more than 70%.  
  • Significant increase of penicillin-resistant Streptococcus penumoniae
    High-level penicillin-resistant Steptococcus pneumoniae increased 1,000-fold over 17 years.  
  • Source of 99,000 annual deaths from HAIs
    Of the 99,000 annual deaths from HAIs: 35,967 are from pneumonia 30,665 are from bloodstream infections 13,088 are from urinary tract infections 8,205 are from surgical site infections; and 11,062 are from infections at other…  
  • Majority of physicians treated patient with at least 1 drug-resistant infection
    63% of surveyed infectious disease physicians treated a patient with at least one drug-resistant infection in 2011. 56% believed those infections to be on the rise.